XBiotech (XBIT)
NASDAQ:XBIT
Total Valuation
XBiotech has a market cap or net worth of $71.65M. The enterprise value is -$53.90M.
Market Cap$71.65M
Enterprise Value-$53.90M
Share Statistics
XBiotech has 30,487,732 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,487,732
Owned by Insiders―
Owned by Institutions1.07%
Financial Efficiency
XBiotech’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -39.17%.
Return on Equity (ROE)-0.32
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-39.17%
Return on Capital Employed (ROCE)-0.39
Revenue Per Employee0.00
Profits Per Employee-495.00K
Employee Count92
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XBiotech is ―. XBiotech’s PEG ratio is -0.09.
PE Ratio―
PS Ratio0.00
PB Ratio0.52
Price to Fair Value0.52
Price to FCF-1.81
Price to Operating Cash Flow-1.79
PEG Ratio-0.09
Income Statement
In the last 12 months, XBiotech had revenue of 0.00 and earned -45.54M in profits. Earnings per share was -1.49.
Revenue0.00
Gross Profit-1.69M
Operating Income-55.69M
Pretax Income-45.30M
Net Income-45.54M
EBITDA-54.00M
Earnings Per Share (EPS)-1.49
Cash Flow
In the last 12 months, operating cash flow was -39.92M and capital expenditures -289.00K, giving a free cash flow of -40.21M billion.
Operating Cash Flow-39.92M
Free Cash Flow-40.21M
Free Cash Flow per Share-1.32
Dividends & Yields
XBiotech pays an annual dividend of $2.47, resulting in a dividend yield of ―
Dividend Per Share$2.47
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change-25.16%
50-Day Moving Average2.39
200-Day Moving Average2.62
Relative Strength Index (RSI)51.05
Average Volume (3m)63.63K
Important Dates
XBiotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
XBiotech as a current ratio of 16.01, with Debt / Equity ratio of 0.00%
Current Ratio16.01
Quick Ratio16.01
Debt to Market Cap0.00
Net Debt to EBITDA2.33
Interest Coverage Ratio-632.78
Taxes
In the past 12 months, XBiotech has paid 235.00K in taxes.
Income Tax235.00K
Effective Tax Rate>-0.01
Enterprise Valuation
XBiotech EV to EBITDA ratio is 0.98, with an EV/FCF ratio of 1.31.
EV to Sales0.00
EV to EBITDA0.98
EV to Free Cash Flow1.31
EV to Operating Cash Flow1.32
Balance Sheet
XBiotech has $125.55M in cash and marketable securities with $0.00 in debt, giving a net cash position of $125.55M billion.
Cash & Marketable Securities$125.55M
Total Debt$0.00
Net Cash$125.55M
Net Cash Per Share$4.12
Tangible Book Value Per Share$4.60
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XBiotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―